P2, N=14, Terminated, H. Lee Moffitt Cancer Center and Research Institute | Trial completion date: Dec 2023 --> May 2022 | Active, not recruiting --> Terminated; Sponsor closed study
P2, N=14, Active, not recruiting, H. Lee Moffitt Cancer Center and Research Institute | Trial completion date: Apr 2024 --> Dec 2023 | Trial primary completion date: Apr 2022 --> Dec 2021
over 3 years ago
Clinical • Trial completion date • Trial primary completion date
|
TP53 (Tumor protein P53) • IFNG (Interferon, gamma)